No abstract available
MeSH terms
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Biomarkers, Tumor / metabolism*
-
Diagnosis, Differential
-
Female
-
Humans
-
Incidence
-
Insulinoma / diagnosis*
-
Insulinoma / mortality
-
Male
-
Mutation
-
Neoplasm Staging
-
Nesidioblastosis / diagnosis*
-
Nesidioblastosis / mortality
-
Neuroendocrine Tumors / diagnosis*
-
Neuroendocrine Tumors / mortality
-
Neuroendocrine Tumors / pathology
-
Neuroendocrine Tumors / therapy
-
Pancreatic Neoplasms / diagnosis*
-
Pancreatic Neoplasms / mortality
-
Pancreatic Neoplasms / pathology
-
Pancreatic Neoplasms / therapy
-
Proto-Oncogene Proteins / metabolism*
-
United States / epidemiology
-
Zollinger-Ellison Syndrome / diagnosis*
-
Zollinger-Ellison Syndrome / mortality
Substances
-
Antineoplastic Agents, Hormonal
-
Biomarkers, Tumor
-
MEN1 protein, human
-
Proto-Oncogene Proteins